Skip to main content
Top
Published in: Advances in Therapy 1/2020

Open Access 01-01-2020 | Melanoma | Practical Approach

Recognising Skin Cancer in Primary Care

Authors: Owain T. Jones, Charindu K. I. Ranmuthu, Per N. Hall, Garth Funston, Fiona M. Walter

Published in: Advances in Therapy | Issue 1/2020

Login to get access

Abstract

Skin cancer, including melanoma, basal cell carcinoma and cutaneous squamous cell carcinoma, has one of the highest global incidences of any form of cancer. In 2016 more than 16,000 people were diagnosed with melanoma in the UK. Over the last decade the incidence of melanoma has increased by 50% in the UK, and about one in ten melanomas are diagnosed at a late stage. Among the keratinocyte carcinomas (previously known as non-melanoma skin cancers), basal cell carcinoma is the most common cancer amongst Caucasian populations. The main risk factor for all skin cancer is exposure to ultraviolet radiation—more than 80% are considered preventable. Primary care clinicians have a vital role to play in detecting and managing patients with skin lesions suspected to be skin cancer, as timely diagnosis and treatment can improve patient outcomes, particularly for melanoma. However, detecting skin cancer can be challenging, as common non-malignant skin lesions such as seborrhoeic keratoses share features with less common skin cancers. Given that more than 80% of skin cancers are attributed to ultraviolet (UV) exposure, primary care clinicians can also play an important role in skin cancer prevention. This article is one of a series discussing cancer prevention and detection in primary care. Here we focus on the most common types of skin cancer: melanoma, squamous cell carcinoma and basal cell carcinoma. We describe the main risk factors and prevention advice. We summarise key guidance on the symptoms and signs of skin cancers and their management, including their initial assessment and referral. In addition, we review emerging technologies and diagnostic aids which may become available for use in primary care in the near future, to aid the triage of suspicious skin lesions.
Literature
1.
go back to reference Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.PubMed Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.PubMed
3.
go back to reference Garbe C, Peris K, Hauschild A, et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline—update 2016. Eur J Cancer. 2016;63:201–17.PubMed Garbe C, Peris K, Hauschild A, et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline—update 2016. Eur J Cancer. 2016;63:201–17.PubMed
4.
go back to reference Mistry M, Parkin DM, Ahmad AS, Sasieni P. Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer. 2011;105(11):1795–803.PubMedPubMedCentral Mistry M, Parkin DM, Ahmad AS, Sasieni P. Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer. 2011;105(11):1795–803.PubMedPubMedCentral
5.
go back to reference Karimkhani C, Boyers LN, Dellavalle RP, Weinstock MA. It’s time for “keratinocyte carcinoma” to replace the term “nonmelanoma skin cancer”. J Am Acad Dermatol. 2015;72(1):186–7.PubMed Karimkhani C, Boyers LN, Dellavalle RP, Weinstock MA. It’s time for “keratinocyte carcinoma” to replace the term “nonmelanoma skin cancer”. J Am Acad Dermatol. 2015;72(1):186–7.PubMed
7.
go back to reference Karia PS. Epidemiology and outcomes of cutaneous squamous cell carcinoma. In: Schmults CD, editor. High-risk cutaneous squamous cell carcinoma: a practical guide for patient management. Berlin: Springer; 2016. p. 3–28. Karia PS. Epidemiology and outcomes of cutaneous squamous cell carcinoma. In: Schmults CD, editor. High-risk cutaneous squamous cell carcinoma: a practical guide for patient management. Berlin: Springer; 2016. p. 3–28.
8.
go back to reference Hiom SC. Diagnosing cancer earlier: reviewing the evidence for improving cancer survival. Br J Cancer. 2015;112(s1):S1–5.PubMedPubMedCentral Hiom SC. Diagnosing cancer earlier: reviewing the evidence for improving cancer survival. Br J Cancer. 2015;112(s1):S1–5.PubMedPubMedCentral
9.
go back to reference Hamilton W, Stapley S, Campbell C, Lyratzopoulos G, Rubin G, Neal RD. For which cancers might patients benefit most from expedited symptomatic diagnosis? Construction of a ranking order by a modified Delphi technique. BMC Cancer. 2015;15(1):820.PubMedPubMedCentral Hamilton W, Stapley S, Campbell C, Lyratzopoulos G, Rubin G, Neal RD. For which cancers might patients benefit most from expedited symptomatic diagnosis? Construction of a ranking order by a modified Delphi technique. BMC Cancer. 2015;15(1):820.PubMedPubMedCentral
10.
go back to reference Swann R, McPhail S, Witt J, et al. Diagnosing cancer in primary care: results from the national cancer diagnosis audit. Br J Gen Pract. 2018;68(666):e63–72.PubMed Swann R, McPhail S, Witt J, et al. Diagnosing cancer in primary care: results from the national cancer diagnosis audit. Br J Gen Pract. 2018;68(666):e63–72.PubMed
11.
go back to reference Public Health England. National Cancer Intelligence Network Be Clear on Cancer: skin cancer awareness local pilot campaign. Interim evaluation results. 2016. London: Public Health England. Public Health England. National Cancer Intelligence Network Be Clear on Cancer: skin cancer awareness local pilot campaign. Interim evaluation results. 2016. London: Public Health England.
13.
go back to reference Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118(8):1130–41.PubMedPubMedCentral Brown KF, Rumgay H, Dunlop C, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. Br J Cancer. 2018;118(8):1130–41.PubMedPubMedCentral
15.
go back to reference Cameron MC, Lee E, Hibler BP, et al. Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2019;80(2):303–17.PubMed Cameron MC, Lee E, Hibler BP, et al. Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2019;80(2):303–17.PubMed
16.
go back to reference Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41(1):28–44.PubMed Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer. 2005;41(1):28–44.PubMed
17.
go back to reference Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146(s61):1–6.PubMed Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146(s61):1–6.PubMed
18.
go back to reference Zak-Prelich M, Narbutt J, Sysa-Jedrzejowska A. Environmental risk factors predisposing to the development of basal cell carcinoma. Dermatol Surg. 2004;30(s2):248–52.PubMed Zak-Prelich M, Narbutt J, Sysa-Jedrzejowska A. Environmental risk factors predisposing to the development of basal cell carcinoma. Dermatol Surg. 2004;30(s2):248–52.PubMed
19.
go back to reference Kallini JR, Hamed N, Khachemoune A. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends. Int J Dermatol. 2015;54(2):130–40.PubMed Kallini JR, Hamed N, Khachemoune A. Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends. Int J Dermatol. 2015;54(2):130–40.PubMed
20.
go back to reference Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353(21):2262–9.PubMed Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353(21):2262–9.PubMed
21.
22.
go back to reference National Institute for Health and Care Excellence. Sunlight exposure: risks and benefits. NG34. London: NICE; 2016. National Institute for Health and Care Excellence. Sunlight exposure: risks and benefits. NG34. London: NICE; 2016.
23.
go back to reference Behavioral Counseling to Prevent Skin Cancer. US preventive services task force recommendation statement. JAMA. 2018;319(11):1134–42. Behavioral Counseling to Prevent Skin Cancer. US preventive services task force recommendation statement. JAMA. 2018;319(11):1134–42.
25.
go back to reference The Royal Australian College of General Practitioners ‘Red Book’ Taskforce. Guidelines for preventive activities in general practice (“The Red Book”). 9th ed. South Melbourne: RACGP; 2018. The Royal Australian College of General Practitioners ‘Red Book’ Taskforce. Guidelines for preventive activities in general practice (“The Red Book”). 9th ed. South Melbourne: RACGP; 2018.
26.
go back to reference Williams AL, Grogan S, Clark-Carter D, Buckley E. Appearance-based interventions to reduce ultraviolet exposure and/or increase sun protection intentions and behaviours: a systematic review and meta-analyses. Br J Health Psychol. 2013;18(1):182–217.PubMed Williams AL, Grogan S, Clark-Carter D, Buckley E. Appearance-based interventions to reduce ultraviolet exposure and/or increase sun protection intentions and behaviours: a systematic review and meta-analyses. Br J Health Psychol. 2013;18(1):182–217.PubMed
28.
go back to reference Wolff T, Tai E, Miller T. Screening for skin cancer : an update of the evidence for the US. Preventive services task force. Ann Intern Med. 2009;150:194–8.PubMed Wolff T, Tai E, Miller T. Screening for skin cancer : an update of the evidence for the US. Preventive services task force. Ann Intern Med. 2009;150:194–8.PubMed
29.
go back to reference Johansson M, Brodersen J, Gotzsche PC, Jorgensen KJ. Screening for reducing morbidity and mortality in malignant melanoma. Cochrane Database Syst Rev. 2019;(6):CD012352. Johansson M, Brodersen J, Gotzsche PC, Jorgensen KJ. Screening for reducing morbidity and mortality in malignant melanoma. Cochrane Database Syst Rev. 2019;(6):CD012352.
30.
go back to reference Williams LH, Shors AR, Barlow WE, Solomon C, White E. Identifying persons at highest risk of melanoma using self-assessed risk factors. J Clin Exp Dermatol Res. 2011;2(6):1000129. Williams LH, Shors AR, Barlow WE, Solomon C, White E. Identifying persons at highest risk of melanoma using self-assessed risk factors. J Clin Exp Dermatol Res. 2011;2(6):1000129.
31.
go back to reference Usher-Smith JA, Emery J, Kassianos AP, Walter FM. Risk prediction models for melanoma: a systematic review. Cancer Epidemiol Biomarkers Prev. 2014;23(8):1450–63.PubMed Usher-Smith JA, Emery J, Kassianos AP, Walter FM. Risk prediction models for melanoma: a systematic review. Cancer Epidemiol Biomarkers Prev. 2014;23(8):1450–63.PubMed
32.
go back to reference Usher-Smith JA, Kassianos AP, Emery JD, et al. Identifying people at higher risk of melanoma across the UK: a primary-care-based electronic survey. Br J Dermatol. 2017;176(4):939–48.PubMed Usher-Smith JA, Kassianos AP, Emery JD, et al. Identifying people at higher risk of melanoma across the UK: a primary-care-based electronic survey. Br J Dermatol. 2017;176(4):939–48.PubMed
33.
go back to reference Hill L, Ferrini RL. Skin cancer prevention and screening: summary of the American College of Preventive Medicine’s practice policy statements. CA Cancer J Clin. 2008;48(4):232–5. Hill L, Ferrini RL. Skin cancer prevention and screening: summary of the American College of Preventive Medicine’s practice policy statements. CA Cancer J Clin. 2008;48(4):232–5.
34.
go back to reference Hoorens I, Vossaert K, Ongenae K, Brochez L. Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening. Br J Dermatol. 2016;174(6):1258–65.PubMed Hoorens I, Vossaert K, Ongenae K, Brochez L. Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening. Br J Dermatol. 2016;174(6):1258–65.PubMed
35.
go back to reference Walter FM, Birt L, Cavers D, et al. “This isn’t what mine looked like”: a qualitative study of symptom appraisal and help seeking in people recently diagnosed with melanoma. BMJ Open. 2014;4(7):1–12. Walter FM, Birt L, Cavers D, et al. “This isn’t what mine looked like”: a qualitative study of symptom appraisal and help seeking in people recently diagnosed with melanoma. BMJ Open. 2014;4(7):1–12.
36.
go back to reference Markovic S, Erickson L, Rao R, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007;82(3):364–80.PubMed Markovic S, Erickson L, Rao R, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007;82(3):364–80.PubMed
37.
go back to reference Chamberlain A, Ng J. Cutaneous melanoma–atypical variants and presentations. Aust Fam Physician. 2009;38(7):476–82.PubMed Chamberlain A, Ng J. Cutaneous melanoma–atypical variants and presentations. Aust Fam Physician. 2009;38(7):476–82.PubMed
38.
go back to reference Thomas NE, Kricker A, Waxweiler WT, et al. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study. JAMA Dermatol. 2014;150(12):1306–14.PubMedPubMedCentral Thomas NE, Kricker A, Waxweiler WT, et al. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study. JAMA Dermatol. 2014;150(12):1306–14.PubMedPubMedCentral
39.
go back to reference Muinonen-Martin AJ, O’Shea SJ, Newton-Bishop J. Amelanotic melanoma. BMJ. 2018;360:k826.PubMed Muinonen-Martin AJ, O’Shea SJ, Newton-Bishop J. Amelanotic melanoma. BMJ. 2018;360:k826.PubMed
40.
go back to reference Newton-Bishop J, Bataille V, Gavin, et al. The prevention, diagnosis, referral and management of melanoma of the skin: concise guidelines. Royal College of Physicians & British Association of Dermatologists. Concise guidance to good practice series, no. 7. London: RCP; 2007. Newton-Bishop J, Bataille V, Gavin, et al. The prevention, diagnosis, referral and management of melanoma of the skin: concise guidelines. Royal College of Physicians & British Association of Dermatologists. Concise guidance to good practice series, no. 7. London: RCP; 2007.
41.
go back to reference National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. NG12. London: NICE; 2015. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. NG12. London: NICE; 2015.
42.
go back to reference Walter FM, Prevost AT, Vasconcelos J, et al. Using the 7-point checklist as a diagnostic aid for pigmented skin lesions in general practice: a diagnostic validation study. Br J Gen Pract. 2013;63(610):e345–53.PubMedPubMedCentral Walter FM, Prevost AT, Vasconcelos J, et al. Using the 7-point checklist as a diagnostic aid for pigmented skin lesions in general practice: a diagnostic validation study. Br J Gen Pract. 2013;63(610):e345–53.PubMedPubMedCentral
43.
go back to reference Ward WH, Lambreton F, Goel N, Yu JQ, Farma JM. Clinical presentation and staging of melanoma. Cutaneous melanoma: etiology and therapy. Brisbane: Codon; 2017. Ward WH, Lambreton F, Goel N, Yu JQ, Farma JM. Clinical presentation and staging of melanoma. Cutaneous melanoma: etiology and therapy. Brisbane: Codon; 2017.
44.
go back to reference Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1985;35(3):130–51.PubMed Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1985;35(3):130–51.PubMed
45.
go back to reference National Institute for Health and Care Excellence. Cancer services guideline: improving outcomes for people with skin tumours including melanoma. CSG8. London: NICE; 2006. National Institute for Health and Care Excellence. Cancer services guideline: improving outcomes for people with skin tumours including melanoma. CSG8. London: NICE; 2006.
46.
go back to reference Murchie P, Adam R, Khor WL, et al. Impact of rurality on processes and outcomes in melanoma care: results from a whole-Scotland melanoma cohort in primary and secondary care. Br J Gen Pract. 2018;68(673):e566–75.PubMedPubMedCentral Murchie P, Adam R, Khor WL, et al. Impact of rurality on processes and outcomes in melanoma care: results from a whole-Scotland melanoma cohort in primary and secondary care. Br J Gen Pract. 2018;68(673):e566–75.PubMedPubMedCentral
47.
go back to reference Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol. 2013;68(3):441–51.PubMed Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. J Am Acad Dermatol. 2013;68(3):441–51.PubMed
48.
go back to reference Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–90.PubMed Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–90.PubMed
49.
go back to reference Motley RJ, Preston PW, Lawrence CM. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. London: British Association of Dermatologists; 2009. Motley RJ, Preston PW, Lawrence CM. Multi-professional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. London: British Association of Dermatologists; 2009.
51.
go back to reference New Zealand Guidelines Group. Suspected cancer in primary care. Wellington: Ministry of Health; 2009. New Zealand Guidelines Group. Suspected cancer in primary care. Wellington: Ministry of Health; 2009.
52.
go back to reference Kwiek B, Schwartz RA. Keratoacanthoma (KA): an update and review. J Am Acad Dermatol. 2016;74(6):1220–33.PubMed Kwiek B, Schwartz RA. Keratoacanthoma (KA): an update and review. J Am Acad Dermatol. 2016;74(6):1220–33.PubMed
53.
go back to reference National Institute for Health and Care Excellence. Improving outcomes for people with skin tumours including melanoma: evidence update October 2011. London: NICE; 2011. National Institute for Health and Care Excellence. Improving outcomes for people with skin tumours including melanoma: evidence update October 2011. London: NICE; 2011.
54.
go back to reference Mcclain SE, Mayo KB, Shada AL, Smolkin ME, Patterson JW, Slingluff CL. Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences. Int J Dermatol. 2012;51(4):420–6.PubMedPubMedCentral Mcclain SE, Mayo KB, Shada AL, Smolkin ME, Patterson JW, Slingluff CL. Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences. Int J Dermatol. 2012;51(4):420–6.PubMedPubMedCentral
55.
go back to reference Maloney ME, Jones DB, Mack Sexton F. Pigmented basal cell carcinoma: investigation of 70 cases. J Am Acad Dermatol. 1992;27(1):74–8.PubMed Maloney ME, Jones DB, Mack Sexton F. Pigmented basal cell carcinoma: investigation of 70 cases. J Am Acad Dermatol. 1992;27(1):74–8.PubMed
56.
go back to reference Salasche SJ, Amonette RA. Morpheaform basal-cell epitheliomas. J Dermatol Surg Oncol. 1981;7(5):387–94.PubMed Salasche SJ, Amonette RA. Morpheaform basal-cell epitheliomas. J Dermatol Surg Oncol. 1981;7(5):387–94.PubMed
57.
go back to reference Royal College of General Practitioners. Guidance and competences to support the accreditation of GPs with Extended Roles (GPwERs) in dermatology and skin surgery. London: RCP; 2018. Royal College of General Practitioners. Guidance and competences to support the accreditation of GPs with Extended Roles (GPwERs) in dermatology and skin surgery. London: RCP; 2018.
58.
go back to reference Rosendahl C, Cameron A, McColl I, Wilkinson D. Dermatoscopy in routine practice—“chaos and clues”. Aust Fam Physician. 2012;41(7):482–7.PubMed Rosendahl C, Cameron A, McColl I, Wilkinson D. Dermatoscopy in routine practice—“chaos and clues”. Aust Fam Physician. 2012;41(7):482–7.PubMed
59.
go back to reference National Institute for Health and Care Excellence. Melanoma: assessment and management. NG14. London: NICE; 2015. National Institute for Health and Care Excellence. Melanoma: assessment and management. NG14. London: NICE; 2015.
60.
go back to reference Argenziano G, Cerroni L, Zalaudek I, et al. Accuracy in melanoma detection: a 10-year multicenter survey. J Am Acad Dermatol. 2012;67(1):54–9.PubMed Argenziano G, Cerroni L, Zalaudek I, et al. Accuracy in melanoma detection: a 10-year multicenter survey. J Am Acad Dermatol. 2012;67(1):54–9.PubMed
63.
go back to reference Jones O, Jurascheck L, van Melle M, et al. Dermoscopy for melanoma detection and triage in primary care: a systematic review. BMJ Open. 2019;9(8):e027529.PubMedPubMedCentral Jones O, Jurascheck L, van Melle M, et al. Dermoscopy for melanoma detection and triage in primary care: a systematic review. BMJ Open. 2019;9(8):e027529.PubMedPubMedCentral
65.
go back to reference Walter FM, Morris HC, Humphrys E, et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ. 2012;345(7866):e4110.PubMedPubMedCentral Walter FM, Morris HC, Humphrys E, et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ. 2012;345(7866):e4110.PubMedPubMedCentral
66.
go back to reference Wilson ECF, Emery JD, Kinmonth AL, et al. The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model. Value Health. 2013;16(2):356–66.PubMed Wilson ECF, Emery JD, Kinmonth AL, et al. The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model. Value Health. 2013;16(2):356–66.PubMed
67.
go back to reference Fujisawa Y, Otomo Y, Ogata Y, et al. Deep-learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumour diagnosis. Br J Dermatol. 2019;180(2):373–81.PubMed Fujisawa Y, Otomo Y, Ogata Y, et al. Deep-learning-based, computer-aided classifier developed with a small dataset of clinical images surpasses board-certified dermatologists in skin tumour diagnosis. Br J Dermatol. 2019;180(2):373–81.PubMed
68.
go back to reference Tschandl P, Codella N, Akay BN, et al. Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: an open, web-based, international, diagnostic study. Lancet Oncol. 2019;20(7):938–47.PubMedPubMedCentral Tschandl P, Codella N, Akay BN, et al. Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: an open, web-based, international, diagnostic study. Lancet Oncol. 2019;20(7):938–47.PubMedPubMedCentral
73.
go back to reference Mogensen M, Jemec GBE. Diagnosis of nonmelanoma skin cancer/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies. Dermatol Surg. 2007;33(10):1158–74.PubMed Mogensen M, Jemec GBE. Diagnosis of nonmelanoma skin cancer/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies. Dermatol Surg. 2007;33(10):1158–74.PubMed
Metadata
Title
Recognising Skin Cancer in Primary Care
Authors
Owain T. Jones
Charindu K. I. Ranmuthu
Per N. Hall
Garth Funston
Fiona M. Walter
Publication date
01-01-2020
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 1/2020
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-019-01130-1

Other articles of this Issue 1/2020

Advances in Therapy 1/2020 Go to the issue